CONTROLLED SUBSTANCE REPORTING                                                       S.B. 47 (S-5):

                                                                                                    SUMMARY OF BILL

                                                                                                  ON THIRD READING

 

 

 

 

 

 

 

 

 

Senate Bill 47 (Substitute S-5 as reported by the Committee of the Whole)

Sponsor:  Senator Dale W. Zorn

Committee:  Health Policy

 


CONTENT

 

The bill would amend the Public Health Code to delete a provision under which rules promulgated by the Department of Licensing and Regulatory Affairs must exempt from reporting requirements the administration of a controlled substance directly to a patient.

 

Instead, under the bill, the following would apply for the purposes of reporting to the electronic monitoring system:

 

--    The dispensing of a controlled substance in a hospital that administers a controlled substance to an inpatient would be exempt from the reporting requirements, and, as currently required, the dispensing from a health facility or agency of a controlled substance in a quantity adequate to treat a patient for not more than 48 hours would be exempt.

--    A dispensing prescriber would have to report certain data to the electronic system for monitoring Schedule 2, 3, 4, and 5 controlled substances if the prescriber dispensed buprenorphine, or a drug containing buprenorphine or methadone, in a substance use disorder program and the patient consented.

 

The bill also would rescind an administrative rule that exempts a pharmacist, prescriber, or veterinarian from the reporting requirements in circumstances involving the administration of a controlled substance directly to a patient and the dispensing of a controlled substance in a health facility or agency in a quantity to treat a patient for not more than 48 hours.

 

The Code requires the Department to establish, by rule, an electronic system for monitoring Schedule 2, 3, 4, and 5 controlled substances dispensed in Michigan by veterinarians, and by pharmacists and dispensing prescribers (physicians and dentists who dispense prescription drugs to their own patients); or dispensed to a Michigan address by a pharmacy licensed in the State.

 

MCL 333.7333a                                                       Legislative Analyst:  Stephen Jackson

 

FISCAL IMPACT

 

The bill would have no fiscal impact on State or local government.

 

Date Completed:  6-21-17                                                     Fiscal Analyst:  Josh Sefton

 

 

 

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.